版本:
中国

BRIEF-Janssen receives CHMP positive opinion for Stelara (Ustekinumab)

Sept 16 Janssen-Cilag International NV

* Janssen receives CHMP positive opinion for Stelara (Ustekinumab) recommending approval for the treatment of moderately to severely active Crohn's disease in the European Union

* Following this positive opinion, a final decision from European Commission is expected later this year

* Ustekinumab was generally well tolerated as an induction and maintenance therapy in all three studies Source text for Eikon:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐